Systemic sclerosis in childhood

Area of Science:

• Pediatric Rheumatology
• Rare Childhood Diseases
• Autoimmune Disorders

Background:

• Juvenile systemic sclerosis (jSSc) is a rare autoimmune condition affecting children.
• Limited published data exists for jSSc, necessitating further research.
• jSSc exhibits distinct clinical presentations and organ involvement patterns compared to adult systemic sclerosis.

Purpose of the Study:

• To summarize current knowledge on juvenile systemic sclerosis.
• To highlight differences between juvenile and adult systemic sclerosis.
• To identify gaps in pediatric jSSc research, particularly regarding treatment and outcome measures.

Main Methods:

• Review of existing literature on juvenile systemic sclerosis.
• Comparison of clinical features and prognosis between pediatric and adult populations.
• Analysis of current research status for outcome measures and treatment efficacy.

Main Results:

• Juvenile systemic sclerosis presents differently from adult-onset disease, with a limited subset of children affected by the limited form.
• Organ involvement patterns in jSSc differ from those observed in adults.
• The prognosis for jSSc is notably better, with a 5-year survival rate of 95%.

Conclusions:

• Juvenile systemic sclerosis is a distinct entity with a better prognosis than adult systemic sclerosis.
• Validated outcome measures and pediatric-specific treatment data are crucial for advancing jSSc care.
• Paediatric rheumatologists currently rely on adult disease data for treatment decisions in jSSc.